Agenda
- All
- February 23, 2026
- February 24, 2026
- February 25, 2026
February 23, 2026
8:30 a.m. - 7:00 p.m.
Registration
February 23, 2026
8:45 a.m. - 10:00 a.m.
Science and Regulatory Working Group
(members only)
February 23, 2026
10:30 a.m. - 12:00 p.m.
Policy and WashRep Meeting
(members only)
February 23, 2026
12:00 p.m. - 1:00 p.m.
Board Meeting Luncheon
(board members and invited guests)
February 23, 2026
1:00 p.m. – 5:00 p.m.
AAM Board of Directors Meeting
(board members and invited guests only)
February 23, 2026
5:00 p.m. - 6:00 p.m.
Access! 2026 Business Exposition Meet & Greet
February 23, 2026
6:00 p.m. - 7:30 p.m.
Welcome Reception
February 24, 2026
7:30 a.m. – 6:00 p.m.
Registration
February 24, 2026
7:30 a.m. - 8:30 a.m.
Networking Breakfast
February 24, 2026
8:30 a.m. – 8:45 a.m.
Welcome to Access! 2026
John Murphy III
President and CEO, AAM
February 24, 2026
8:45 a.m. – 9:00 a.m.
Access! Awards Presentation
February 24, 2026
9:00 a.m. – 9:30 a.m.
Keynote Address
February 24, 2026
9:30 a.m. – 10:00 a.m.
Networking Break
February 24, 2026
10:00 a.m. – 10:30 a.m.
Healthcare Innovation and the Political Economy: The Perspective of a Former Commissioner
Scott Gottlieb, M.D.
Former Commissioner, FDA
Former Senior Advisor, CMS
Moderator: John Murphy III
President and CEO, AAM
February 24, 2026
10:30 a.m. – 11:30 a.m.
Panel Discussion
February 24, 2026
11:30 a.m. - 1:00 p.m.
Networking Luncheon
February 24, 2026
1:00 p.m. - 1:30 p.m.
Fireside Chat with Reid Strategic
Communication about the value of pharmaceuticals is increasingly important, with the role of generics and biosimilars becoming clear at a time where the overall pharmaceutical ecosystem has been thrust into turmoil by dramatic policy proposals.
There is a need to put those policy efforts in a broader context to ensure that there is an understanding of how entire life science ecosystem – from the very earliest stages of discovery to the critical effort to make generic medicines widely available – fits together to drive maximal value for patients and society.
As such, there is a need for continuing education on the current landscape around external discussion of policy value, including different objectives, audiences to be considered, strategic approaches, and tactical considerations.
Brian Reid
Founder and Principal, Reid Strategic
Senior Fellow, Tufts’ Center for the Evaluation of Value and Risk in Health
Moderator: Alex Keeton
Executive Director, Biosimilars Council
Senior Vice President, Policy, AAM
February 24, 2026
1:30 p.m. - 2:30 p.m.
Panel Discussion
February 24, 2026
02:30 p.m. - 03:30 p.m.
State Affairs Working Group
(members only)
February 24, 2026
03:30 p.m. - 04:30 p.m.
Biosimilars Council
(members only)
February 24, 2026
02:30 p.m. - 05:00 p.m.
Access! 2026 Business Exposition Hall
February 24, 2026
5:00 p.m. - 8:00 p.m.
Networking Reception/Dinner and Entertainment
February 25, 2026
7:00 a.m. – 8:00 a.m.
Networking Breakfast
February 25, 2026
8:00 a.m. – 10:00 a.m.
General Sessions
February 25, 2026
10:30 a.m. – 10:30 a.m.
Networking Break
February 25, 2026
10:00 a.m. – 11:00 a.m.
Global and U.S. Generics and Biosimilars: Trends, Issues and Outlook
Dive into the dynamics of global and U.S. generic and biosimilar markets. This session will examine market share trends, leading companies, fast-growing generic molecules and classes, ANDA approval patterns, retail pharmacy closures, drug shortages, and price deflation. Gain insights into biosimilar trends and future patent expirations shaping the industry’s future.
Scott Biggs
Director, Supplier Services, IQVIA
February 25, 2026
11:00 a.m. – 12:15 p.m.
CEOs Unplugged
Join us for an engaging session where global industry leaders take the stage to discuss the future of generics and biosimilars. This dynamic conversation will delve into pressing challenges, emerging opportunities, and innovative strategies shaping the healthcare landscape. In this exclusive forum, CEOs will share insights on leadership, navigating market disruptions, and driving progress—while also fielding candid questions.
February 25, 2026
12:15 p.m. – 12:30 p.m.
Closing Remarks
John Murphy III
President and CEO, AAM
February 25, 2026
12:30 p.m. – 01:30 p.m.
Access! 2026 Farewell Luncheon
February 25, 2026
01:30 p.m.
Access! 2026 Concludes
*Agenda is subject to change
